Impact of Perioperative Blood Transfusions on Outcomes After Hyperthermic Intraperitoneal Chemotherapy: A Propensity-Matched Analysis-Reference-Cited by-同舟云学术

Impact of Perioperative Blood Transfusions on Outcomes After Hyperthermic Intraperitoneal Chemotherapy: A Propensity-Matched Analysis

Published:2021-01-28 Issue:8 Volume:28 Page:4499-4507
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Kubi Boateng,Nudotor Richard,Fackche Nadege,Nizam Wasay,Cloyd Jordan M.,Grotz Travis E.,Fournier Keith F.,Dineen Sean P.,Powers Benjamin D.,Veerapong Jula,Baumgartner Joel M.,Clarke Callisia N.,Patel Sameer H.,Lambert Laura A.,Abbott Daniel E.,Vande Walle Kara A.,Raoof Mustafa,Lee Byrne,Maithel Shishir K.,Staley Charles A.,Johnston Fabian M.,Greer Jonathan B.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-020-09501-7.pdf

Reference44 articles.

1. de Cuba EM, Kwakman R, Knol DL, Bonjer HJ, Meijer GA, Te Velde EA. Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: systematic review of all literature and meta-analysis of observational studies. Cancer Treat Rev. 2013;39: 321–7. https://doi.org/10.1016/j.ctrv.2012.11.003.

2. Glehen O, Mohamed F, Gilly FN. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol. 2004;5:219–28. https://doi.org/10.1016/s1470-2045(04)01425-1.

3. Beal EW, Ahmed A, Grotz T, et al. Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Am J Surg. 2020;219:478–83.

4. Glehen O, Osinsky D, Cotte E, et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol. 2003;10:863–9. https://doi.org/10.1245/aso.2003.01.018.

5. Mercier F, Dagbert F, Pocard M, et al. Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. BJS Open. 2018;3:195–202. https://doi.org/10.1002/bjs5.97.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Explaining the Elusive Nature of a Well-Defined Threshold for Blood Transfusion in Advanced Epithelial Ovarian Cancer Cytoreductive Surgery;Diagnostics;2023-12-30

2. Prediction of Early Recurrence Following CRS/HIPEC in Patients With Disseminated Appendiceal Cancer;Journal of Surgical Research;2023-12

3. Risk factors for gastrointestinal perforation and anastomotic leak in patients submitted to cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC);European Journal of Surgical Oncology;2023-10

4. Evaluating the Efficacy and Safety of a Single-Dose Tranexamic Acid in Reducing Blood Loss During Cytoreductive Surgery Followed by Hyperthermic Intraperitoneal Chemotherapy: A Randomized Comparative Pilot Study;Anesthesiology and Pain Medicine;2023-07-02

5. Absolute Iron Deficiency Anemia Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy;Annals of Surgical Oncology;2023-02-25